GSK PLC GSK shares slipped 2.45% to £15.36 Friday, on what proved to be an all-around grim trading session for the stock ...

Mirvetuximab soravtansine was the first ADC to show efficacy as a therapy for platinum-resistant ovarian cancer. Despite high ...

Obermair called for his fellow gynecological cancer surgeons to join him in interrogating current standards of practice.

GET MORE AI-GENERATED SIGNALS: September 19, 2024, 20:16 pm ET, BY Jeff W.- Contributor| Editor: Thomas H. Kee Jr. ( Follow ...

Topline results were announced from a phase 3 study assessing the immune response following coadministration of Arexvy and Shingrix.

Data from a late-stage study shows that co-administering GSK's RSV and Shingles vaccines together was as effective as giving each separately.

An Illinois mistrial involving the recalled medication Zantac is the latest court decision involving the recalled drug, but ...

Our Fool likes the look of these stock market juggernauts for the chunky passive income they throw off, not to mention their ...

Before the FDA approved AstraZeneca’s Fasenra, Nucala was the only therapy for treating eosinophilic granulomatosis with ...

Global stock markets are set for a positive weekly close following the Fed’s jumbo rate cuts. The Bank of England’s hawkish ...

Until recently, the pharmaceutical industry remained relatively insulated from the simmering trade war between China and the ...

Moderna should not be left off the list of interesting investment opportunities, as the company has one of the best pipelines ...